000 01118nam a2200325 a 4500
005 20250914093949.0
008 001019s2000 xxu 000 0 eng b
010 _a99-33655
020 _a0683306545
_cRM522.60
039 9 _a200010191453
_bamin
_y10-19-2000
_zamin
060 _aQZ267
090 _aQZ267.H638 1999 9HUKM
245 0 0 _aHigh-dose cancer therapy :
_bpharmacology, hematopoietins, stem cells /
_cedited by James O. Armitage, Karen H. Antman
250 _a3rd ed.
260 _aPhiladelphia :
_bLippincott Williams & Wilkins,
_c2000
300 _a951 p. :
_c26 cm.
650 1 2 _aNeoplasms
_xDrug therapy
650 2 2 _aAntineoplastic agents
_xPharmacology
650 2 2 _aDose-Response Relationship, Drug
650 2 2 _aHematopoietic Cell Growth Factors
_xtherapeutic use
700 1 _aArmitage, James O.
700 1 _aAntman, Karen H.
907 _a.b12746976
_b2019-11-12
_c2019-11-12
942 _c01
_n0
_kQZ267.H638 1999 9HUKM
914 _avtls000284139
990 _aAmin
991 _aJabatan Patologi, HUKM
998 _ah
_b2000-06-10
_cm
_da
_feng
_gxxu
_y0
_z.b12746976
999 _c275383
_d275383